Filing Flows

Filing Flows › Envoy Medical (COCH) › Next earnings date

Envoy Medical (COCH) earnings: beat the estimate

Envoy Medical (COCH) reported on Nov 5, 2026 and beat the EPS estimate: −$0.50 against −$0.67 (+25.4%). Revenue was $66K for Q3 2026, +57% year over year. It beat the EPS estimate in 75% of the quarters on record.

Last result+25.4% vs estimate
Beat rate75%

The last report

Envoy Medical reported revenue of $66K for the third quarter 2026 (+57% Y/Y), net loss $3.9M. How it makes money → · Every quarter →

Envoy Medical: EPS against the estimate, last 4 reportsEnvoy Medical: EPS against the estimate, last 4 reportsEstimateReported−$2.87−$3.50Nov 25−$1.40−$0.80May 26−$0.80−$0.70Aug 26−$0.67−$0.50Nov 26
Latest (Nov 26): Estimate −$0.67, Reported −$0.50.

Envoy Medical's latest quarter

Envoy Medical, Q3 2026: revenue $66K (+57% year over year), net loss $3.9M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did Envoy Medical beat earnings?

Envoy Medical (COCH) reported on Nov 5, 2026 and beat the EPS estimate: −$0.50 against −$0.67 (+25.4%).

When does COCH report earnings?

The next date is not set yet.

Does Envoy Medical usually beat earnings?

It beat the consensus EPS estimate in 75% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.